Subramanian Swamy Calls for Ban on Cement Imports From Pakistan Citing Security Risks Sebi Exposes Alleged PumpandDump Scheme Across 82 SME Stocks Impounds Rs 2025 Crore Tulsi Gabbard Resigns as US Director of National Intelligence Leadership Transition Could Influence National Security Policy European Manufacturers Maintain China Supply Chains Amid EU DeRisking Efforts Qualcomms Rally Signals Growing Investor Confidence in AI Device Boom Egypt QatarEnergy and ExxonMobil Partner to Ship Cypriot Gas to Europe via Egyptian LNG Facilities Revelation Biosciences Inc REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Continues Development MARPS Q4 2025 Earnings Royalty Income Holds Steady Amid No Revenue Expectation LINC Q1 2026 Earnings EPS Surpasses Estimates with 2111 Surprise Modular Medical Inc MODD Q3 2025 Earnings Narrowed Loss Per Share Despite Surprise Miss Stock Rises 458 TME Q1 2026 Earnings EPS Beat Fails to Lift Shares LendingClub LC Q1 2026 Earnings EPS Surpasses Expectations as Stock Edges Lower Alpha Cognition Inc ACOG Edges Higher as Price Consolidates Near Key Resistance Edible Garden Warrant EDBLW Edges Lower Holds at Key 007 Support Hyperfine Inc HYPR Slides 271 as Stock Tests Critical Support Levels Auddia Inc AUUD Slides 688 as Sellers Test Key Support Near 142 Cardio Diagnostics Holdings Warrant CDIOW Stays at Penny Level Amid Minimal Price Change UK Proposes Single Market for Goods with EU as Part of Broader Trade Reset Weyco Group Q1 2026 Earnings Steady EPS Performance Amid Challenging Retail Environment Birkenstock BIRK Surges 46 Rebounds from Support Eyes Resistance Fortune Brands Innovations FBIN Surges 44 Key Levels to Watch UMH Properties Inc UMH Slips 097 as Stock Tests Key Support Zone Enovix ENVX Surges Over 6 as Bulls Test Key Resistance at 701 DMO Edges Higher Western Asset Mortgage Opportunity Fund Shows Modest Gains Qfin Holdings QFIN Drops 24 as Stock Approaches Key Support Zone Oyster Enterprises II Acquisition Corp Units OYSEU Holds Steady at 1031 as SPAC Units Trade in Narrow Range Foghorn Therapeutics FHTX Rises 144 as Biotech Stock Tests Key Resistance at 443